Mirtazepine for MDMA-induced depression.
Fetter
Jeffrey C
JC
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D003866:Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects
D000929:Antidepressive Agents, Tricyclic; D006213:Hallucinogens; D008803:Mianserin; D000078785:Mirtazapine; D018817:N-Methyl-3,4-methylenedioxyamphetamine